Enabled by technology: Unified pricing & market access intelligence
Transform pharmaceutical pricing from complexity to clarity with our technology enabled platform. Maximise asset ROI from lab to launch with unified intelligence that eliminates guesswork and accelerates strategic decisions.
What sets us apart
- Data-driven strategies
- Proven results
- Scalable growth
- Trusted expertise
What Sets Us Apart
- Data-Driven Strategies
- Proven Results
- Scalable Growth
- Trusted Expertise
Your command centre for pricing & market access
Data
complexity
- Multiple, fragmented data sources in different formats
- Manual consolidation taking weeks of effort
- Inconsistent data across countries and regions
Time & resource constraints
- Small teams handling multiple projects simultaneously
- Increasing workload with leadership pressure
- Limited bandwidth to analyze and act on insights
Dynamic market conditions
- Continuously evolving competitor landscape
- Frequent pricing and reimbursement policy changes
- Varying price levels across countries
Power your pharmaceutical strategy with intelligent capabilities
Technology enabled insights
- Conversational assistance of natural queries
- Instant, context-aware answers
- Accessible demo available
Intuitive digital interface
- Real-time insights on demand
- Multi-market analysis dashboards
- Accessible anywhere, anytime
Curated data export capabilities
- Customisable reports & flexible formats
- Pack-level granularity
- Read-to-use outputs for internal use
Driving success through strategy.
Data-driven insights
- One trusted source for global teams
- Faster, smarter decision-making
- Less manual effort, more strategic focus
- Enterprise-grade security & compliance
Instant insights
Rapid detection of pack and price changes
IRP matrix
Stay ahead of cross-market dependencies with real-time IRP Modelling
Historical trends
Spot anomalies, patterns and market opportunities
Price and cost corridor analysis
Benchmark ranges across markets to guide launch pricing
HTA Insights
Rapid access to published HTA decisions and rationales
Reimbursement tracking
Monitor policies, coverage trends, and access updates.
Country landscape
Map healthcare systems, stakeholders, and access pathways.
Analogue selector
Identify and compare relevant commercial products.
Your time is valuable.
We make every second count.
Our curated data, enabled by technology and guided by specialist pricing expertise is your pharmaceutical market advantage
Curated data
We prioritise strategic clarity, sustainable growth, and measurable impact, ensuring businesses stay ahead in a dynamic market.
Technology enabled
Combining data-driven insights with tailored
solutions, we create actionable strategies that drive real business results.
Specialist expertise
Years of hands-on consulting helping numerous organisations navigate complexity, unlock growth, and achieve lasting transformation.
Global Pricing Innovations
Michelle Pardo
GPI is always ready to listen, flexible, available and amenable to all business needs. Pfizer relies heavily on GPI’s Cost of Treatment calculations in order to determine which products we have to report on, and therefore upholding our reputation.
Marc Gauthier-Darnis
Major impact. As GPI is our only price database provider, we fully trust them… We’ve been working together for a while and GPI has always met our expectations and solved our problems if any.
What our clients say
Change starts with a conversation
Have a challenge or an idea?
Schedule a consultation
By submitting this form you agree to our Privacy Policy. GPI may contact you via email or phone for scheduling or marketing purposes.
Expert strategies, industry trends & real results
Gene therapy JCA submissions face a distinct methodological test, and
Pre-launch price forecasting for rare disease assets was tested against
Evaluate a pharmaceutical pricing data provider on the questions your
Joint Clinical Assessment evidence requirements have been tested twice in
